These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2881734)

  • 21. Role of CCK-A receptor in the regulation of pancreatic bicarbonate secretion in conscious rats: a study in naturally occurring CCK-A receptor gene knockout rats.
    Miyasaka K; Suzuki S; Kanai S; Masuda M; Funakoshi A
    Pancreas; 1999 Oct; 19(3):217-23. PubMed ID: 10505751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous measurement of the pancreatic and biliary response to CCK and secretin. Primate biliary physiology. XIII.
    Gardner BN; Small DM
    Gastroenterology; 1976 Mar; 70(3):403-7. PubMed ID: 814029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of vasoactive intestinal peptide and secretin in stimulation of pancreatic secretion.
    Konturek SJ; Pucher A; Radecki T
    J Physiol; 1976 Feb; 255(2):497-509. PubMed ID: 1255530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of alcohols on the actions of VIP and secretin on acinar cells from guinea pig pancreas.
    Uhlemann ER; Robberecht P; Gardner JD
    Gastroenterology; 1979 May; 76(5 Pt 1):917-25. PubMed ID: 220130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of growth hormone releasing factor on pancreatic secretion in vivo and in vitro.
    Konturek SJ; Bilski J; Jaworek J; Mochizuki T; Yanaihara C; Yanaihara N
    Regul Pept; 1989 Mar; 24(3):301-11. PubMed ID: 2469109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postreceptor modulation of action of VIP and secretin on pancreatic enzyme secretion by secretagogues that mobilize cellular calcium.
    Collen MJ; Sutliff VE; Pan GZ; Gardner JD
    Am J Physiol; 1982 Apr; 242(4):G423-8. PubMed ID: 6175231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
    Gabryelewicz A; Kulesza E; Konturek SJ
    Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similar sensitivities of pancreatic and biliary secretion to cholecystokinin plus secretin infusion.
    Macgregor IL; Knill JR; Meyer JH
    Am J Dig Dis; 1976 Aug; 21(8):641-4. PubMed ID: 952277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation of cholecystokinin and secretin-induced pancreatic exocrine secretion by endogenous insulin in humans.
    Kim C; Kim K; Lee H; Song C; Ryu H; Hyun J
    Pancreas; 1999 May; 18(4):410-4. PubMed ID: 10231848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholecystokinin downregulates receptors for vasoactive intestinal peptide and secretin in rat pancreatic acini.
    Katsushima S; Adachi H; Honda T; Sato S; Kusui T; Onishi S; Aoki E; Noguchi M; Konishi J
    Am J Physiol; 1990 Mar; 258(3 Pt 1):G395-403. PubMed ID: 2156442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of amylase release from dispersed pancreatic acinar cells.
    Gardner JD; Jackson MJ
    J Physiol; 1977 Sep; 270(2):439-54. PubMed ID: 198531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs.
    Konturek SJ; Thor P; Dembinski A; Krol R
    Gastroenterology; 1975 Jun; 68(6):1527-35. PubMed ID: 1132634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Secretin and cholecystokinin: hormonal action on the concentration of vasoactive intestinal polypeptide and gastrin in human subjects?].
    Bauer FE; Schulz E; von Kleist D; Janisch HD; Hampel KE
    Z Gastroenterol; 1984 Aug; 22(8):388-93. PubMed ID: 6485438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptors involved in helodermin action on rat pancreatic acini.
    Dehaye JP; Winand J; Damien C; Gomez F; Poloczek P; Robberecht P; Vandermeers A; Vandermeers-Piret MC; Stiévenart M; Christophe J
    Am J Physiol; 1986 Nov; 251(5 Pt 1):G602-10. PubMed ID: 2430470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PYY potently inhibits pancreatic exocrine secretion mediated through CCK-secretin-stimulated pathways but not 2-DG-stimulated pathways in awake rats.
    Deng X; Guarita DR; Wood PG; Kriess C; Whitcomb DC
    Dig Dis Sci; 2001 Jan; 46(1):156-65. PubMed ID: 11270780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of chronic pentagastrin, cholecystokinin, and secretin on pancreas of rats.
    Petersen H; Solomon T; Grossman MI
    Am J Physiol; 1978 Mar; 234(3):E286-93. PubMed ID: 343601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of pancreatic responses to portal and systemic secretin and VIP in cats.
    Konturek SJ; Domschke S; Domschke W; Wünsch E; Demling L
    Am J Physiol; 1977 Feb; 232(2):E156-8. PubMed ID: 842623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of duodenal alkalinization on pancreatic secretion.
    Takeshima T; Adler M; Nacchiero M; Rudick J; Dreiling DA
    Am J Gastroenterol; 1977 Jan; 67(1):54-62. PubMed ID: 851106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Absence of effect of secretin and cholecystokinin on plasma concentrations of vasoactive intestinal polypeptide and pancreatic glucagon].
    Bauer FE; Schulz E; Janisch HD; von Kleist D; Hampel KE
    Wien Klin Wochenschr; 1985 Jul; 97(14):603-5. PubMed ID: 3901535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholecystokinin and secretin prevent the intestinal mucosal hypoplasia of total parenteral nutrition in the dog.
    Hughes CA; Bates T; Dowling RH
    Gastroenterology; 1978 Jul; 75(1):34-41. PubMed ID: 122602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.